secwatch.observer — SEC 8-K summary
======================================

Issuer:     NRX Pharmaceuticals, Inc. (NRXP)
CIK:        0001719406
Form:       8-K
Filed at:   2025-09-08T23:59:59+00:00
Accession:  0001437749-25-028567
Event type: other_material
Sentiment:  positive
Materiality: 0.65
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

NRx Pharmaceuticals raises $8.8M, announces HOPE Therapeutics launch and Rockefeller advisory role
--------------------------------------------------------------------------------

- Raised $8.8M gross from experienced biotech investors via common stock offering; no warrants or variable rate features.
- HOPE Therapeutics subsidiary to launch in September 2025 with flagship location in Palm Beach, FL.
- Clinics will combine ketamine, transcranial magnetic stimulation, hyperbaric oxygen for suicidal depression, PTSD, TBI.
- Matthew Rockefeller joins HOPE Therapeutics Advisory Board.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1719406/000143774925028567/0001437749-25-028567-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1719406/000143774925028567/nrxp20250908_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-25-028567

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer